A Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of BGB-30813

⟵ Back to Search Results

Beigene Study ID

BGB-A317-30813-101

ClinicalTrials.gov ID

NCT05904496

EudraCT Number

2023-503996-38

Sex: All

Age: 18 Years / N/A

No Study Documents

Locations

Sex: All

Age: 18 Years / N/A

No Study Documents